Evidence map›Paper›PMID 31504285›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

A Rare Mutation in SPLUNC1 Affects Bacterial Adherence and Invasion in Meningococcal Disease.

Bayarchimeg Mashbat, Evangelos Bellos, Stephanie Hodeib, Fadil Bidmos, Ryan S Thwaites, Yaxuan Lu, Victoria J Wright, Jethro A Herberg, Daniela S Klobassa, Werner Zenz and 9 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 5 countries.

Bayarchimeg MashbatDepartment of Paediatric Infectious Diseases, Division of Medicine, Imperial College London, Norfolk Place, United Kingdom.
Evangelos BellosDepartment of Paediatric Infectious Diseases, Division of Medicine, Imperial College London, Norfolk Place, United Kingdom.
Stephanie HodeibDepartment of Paediatric Infectious Diseases, Division of Medicine, Imperial College London, Norfolk Place, United Kingdom.
Fadil BidmosDepartment of Paediatric Infectious Diseases, Division of Medicine, Imperial College London, Norfolk Place, United Kingdom.
Ryan S ThwaitesNational Heart and Lung Institute, Imperial College London, United Kingdom.
Yaxuan LuDepartment of Paediatric Infectious Diseases, Division of Medicine, Imperial College London, Norfolk Place, United Kingdom.
Victoria J WrightDepartment of Paediatric Infectious Diseases, Division of Medicine, Imperial College London, Norfolk Place, United Kingdom.
Jethro A HerbergDepartment of Paediatric Infectious Diseases, Division of Medicine, Imperial College London, Norfolk Place, United Kingdom.
Daniela S KlobassaDepartment of Pediatric and Adolescence Surgery, Division of General Pediatric Surgery, Medical University Graz, Austria.
Werner ZenzDepartment of Pediatric and Adolescence Surgery, Division of General Pediatric Surgery, Medical University Graz, Austria.
Trevor T HanselNational Heart and Lung Institute, Imperial College London, United Kingdom.
Simon NadelPaediatric Intensive Care Unit, St. Mary's Hospital, Imperial College Healthcare Trust, London, United Kingdom.
Paul R LangfordDepartment of Paediatric Infectious Diseases, Division of Medicine, Imperial College London, Norfolk Place, United Kingdom.
Luregn J SchlapbachFaculty of Medicine Brisbane, The University of Queensland Brisbane, Australia.
Ming-Shi LiDepartment of Paediatric Infectious Diseases, Division of Medicine, Imperial College London, Norfolk Place, United Kingdom.
Matthew R RedinboDepartment of Chemistry, University of North Carolina, Chapel Hill.
Y Peter DiDepartment of Environmental and Occupational Health, University of Pittsburgh, Pennsylvania.
Michael LevinDepartment of Paediatric Infectious Diseases, Division of Medicine, Imperial College London, Norfolk Place, United Kingdom.
Vanessa Sancho-ShimizuDepartment of Paediatric Infectious Diseases, Division of Medicine, Imperial College London, Norfolk Place, United Kingdom.
Imperial College London · GBMedical University of Graz · ATSt Mary's Hospital · GBUniversity Hospital of Bern · CHUniversity of North Carolina at Chapel Hill · USUniversity of Pittsburgh · US

Funding

SPLUNC1 in Severe AsthmaR01HL125128 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHU, HONG W, DI, YUANPU PETER · 2015 to 2018
$1.9M
Structural Basis for Hormone and Neurotransmitter Processing by Gut Microbial EnzymesR01GM135218 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI REDINBO, MATTHEW R · 2019 to 2022
$1.5M
NHLBI NIH HHS R01 HL125128NIGMS NIH HHS R01 GM135218
6 · The paper itself

Abstract

backgroundNeisseria meningitidis (Nm) is a nasopharyngeal commensal carried by healthy individuals. However, invasive infections occurs in a minority of individuals, with devastating consequences. There is evidence that common polymorphisms are associated with invasive meningococcal disease (IMD), but the contributions of rare variants other than those in the complement system have not been determined.

methodsWe identified familial cases of IMD in the UK meningococcal disease study and the European Union Life-Threatening Infectious Disease Study. Candidate genetic variants were identified by whole-exome sequencing of 2 patients with familial IMD. Candidate variants were further validated by in vitro assays.

resultsExomes of 2 siblings with IMD identified a novel heterozygous missense mutation in BPIFA1/SPLUNC1. Sequencing of 186 other nonfamilial cases identified another unrelated IMD patient with the same mutation. SPLUNC1 is an innate immune defense protein expressed in the nasopharyngeal epithelia; however, its role in invasive infections is unknown. In vitro assays demonstrated that recombinant SPLUNC1 protein inhibits biofilm formation by Nm, and impedes Nm adhesion and invasion of human airway cells. The dominant negative mutant recombinant SPLUNC1 (p.G22E) showed reduced antibiofilm activity, increased meningococcal adhesion, and increased invasion of cells, compared with wild-type SPLUNC1.

conclusionsA mutation in SPLUNC1 affecting mucosal attachment, biofilm formation, and invasion of mucosal epithelial cells is a new genetic cause of meningococcal disease.

Indexed as

Neisseria meningitidisComplement System ProteinsEpithelial CellsGlycoproteinsHumansMeningococcal InfectionsMutationPhosphoproteinsBPIFA1 protein, humanComplement System ProteinsGlycoproteinsPhosphoproteinshuman geneticsmeningococcal diseasemucosal immunitysepsissevere infectious disease

Identifiers

PMID31504285
PMCPMC7201419
OpenAlexW2956070303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.